3d Printed Drugs Market Scope And Analysis

  • Report Code : TIPRE00010199
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

3D Printed Drugs Market Scope and Key Players Analysis by 2031

Buy Now

3D Printed Drugs Market Report 3D Printed Drugs Market Size and Share 3D Printed Drugs Market Scope and Analysis

3D Printed Drugs Market Report Scope

Report Attribute Details
Market size in 2023 US$ 33.58 Million
Market Size by 2031 US$ 83.08 Million
Global CAGR (2023 - 2031) 9.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Dosage Forms
  • Tablets
  • Capsules
  • Multi Drug Implant
  • Nanoparticles
  • Solutions
By Technology
  • Inkjet Printing
  • Direct Write
  • Zip Dose
  • Thermal Inkjet Printing
  • Fused Deposition Modeling
  • Powder Bed Printing
  • Stereolithography
  • Semi Solid Extrusion
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • APRECIA PHARMACEUTICALS LLC
  • FabRx LTD
  • Cycle Pharmaceuticals
  • GLAXOSMITHKLINE PLC
  • ASTRAZENECA
  • Tvasta
  • Merck KGGA
    		•
    (KEEP THIS KEYWORD HERE FOR SHYAM)

    “

    DO NOT ADD ANY TABLE HERE

    ”

    3D Printed Drugs Market News and Recent Developments

    The 3D printed drugs market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

    • In October, 2023, Finnish healthtech company CurifyLabs has announced the launch first in the world GMP (good manufacturing practice) produced Pharma Inks for 3D printable medicines. CurifyLabs’ Pharma Kit, including automated 3D printing technology and printable pharmaceutical inks, enables wider adoption of personalised medicine, resulting in better future care for patients with different needs according to the company. (Source: CurifyLabs, Press Release)
    • In September 2023, LSMU (Lithuanian University of Health Sciences)launches the first validated pharmaceutical 3D Printer.  The new device sets a new course for innovation development in pharmaceutical technologies. It allows to produce personalised medicine tailored to each individual patient, increase the efficacy of medicines by combining several substances in a single tablet and reducing the side effects of medicines. (Source: LSMU, Press Release)

    3D Printed Drugs Market Report Coverage and Deliverables

    The “3D Printed Drugs Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

    • 3D Printed Drugs Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • 3D Printed Drugs Market trends
    • Detailed PEST and SWOT analysis
    • 3D Printed Drugs market analysis covering key market trends, Global and regional framework, major players, regulations, and recent market developments.
    • 3D Printed DrugsIndustry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments.
    • Detailed company profiles